Merck to Present New Data on Investigational Chronic Hepatitis C Treatment

Merck to Present New Data on Investigational Chronic Hepatitis C Treatment … KENILWORTH, N.J., Oct 20, 2015 (BUSINESS WIRE) — Merck MRK, +1.67% known as MSD outside the United States and Canada, today announced that new data from clinical trials … Continue reading

AbbVie to Present New Data from Hepatitis C Clinical Development Program at

AbbVie to Present New Data from Hepatitis C Clinical Development Program at … VIEKIRAX and EXVIERA are not recommended as monotherapy and should be used in combination with other medicinal products for the treatment of hepatitis C infection. Pregnancy and … Continue reading